(Q41604732)

5 October 2017

1 reference

title

Toward clinical trials of DNA vaccines against malaria (English)

1 reference

5 October 2017

1 reference

1 reference

1

Hoffman SL

1 reference

5 October 2017

Doolan DL

2

1 reference

5 October 2017

Sedegah M

3

1 reference

5 October 2017

Wang R

4

1 reference

5 October 2017

Scheller LF

5

1 reference

5 October 2017

Kumar A

6

1 reference

5 October 2017

Weiss WR

7

1 reference

5 October 2017

Le TP

8

1 reference

5 October 2017

Klinman DM

9

1 reference

5 October 2017

Hobart P

10

1 reference

5 October 2017

Norman JA

11

1 reference

5 October 2017

Hedstrom RC

12

1 reference

5 October 2017

publication date

1 August 1997

1 reference

Immunology & Cell Biology

5 October 2017

published in

1 reference

5 October 2017

volume

75

1 reference

5 October 2017

issue

4

1 reference

5 October 2017

page(s)

376-381

1 reference

Multi-gene vaccination against malaria: A multistage, multi-immune response approach

5 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FICB.1997.59

Letter: Sporozoite induced immunity in man against an Ethiopian strain of Plasmodium falciparum

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1997.59

Long-term persistence of sterile immunity in a volunteer immunized with X-irradiated Plasmodium falciparum sporozoites

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1997.59

Gamma interferon, CD8+ T cells and antibodies required for immunity to malaria sporozoites

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1997.59

CD8+ T cells (cytotoxic/suppressors) are required for protection in mice immunized with malaria sporozoites

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1997.59

Induction of nitric oxide synthase protects against malaria in mice exposed to irradiated Plasmodium berghei infected mosquitoes: involvement of interferon gamma and CD8+ T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1997.59

Cloned cytotoxic T cells recognize an epitope in the circumsporozoite protein and protect against malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1997.59

CD8+ cytolytic T cell clones derived against the Plasmodium yoelii circumsporozoite protein protect against malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1997.59

Inhibition of development of exoerythrocytic forms of malaria parasites by gamma-interferon

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1997.59

Interleukin 12 induction of interferon gamma-dependent protection against malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1997.59

Sterile protection of monkeys against malaria after administration of interleukin-12.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1997.59

Irradiated sporozoite vaccine induces cytotoxic T lymphocytes that recognize malaria antigens on the surface of infected hepatocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1997.59

Cytotoxic T cells recognize a peptide from the circumsporozoite protein on malaria-infected hepatocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1997.59

Oral Salmonella typhimurium vaccine expressing circumsporozoite protein protects against malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1997.59

Oral Salmonella: malaria circumsporozoite recombinants induce specific CD8+ cytotoxic T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1997.59

Recombinant pseudorabies virus carrying a plasmodium gene: herpesvirus as a new live viral vector for inducing T- and B-cell immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1997.59

Priming with recombinant influenza virus followed by administration of recombinant vaccinia virus induces CD8+ T-cell-mediated protective immunity against malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1997.59

Protection against malaria by vaccination with sporozoite surface protein 2 plus CS protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1997.59

Salmonella typhi vaccine strain CVD 908 expressing the circumsporozoite protein of Plasmodium falciparum: strain construction and safety and immunogenicity in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1997.59

Protection against malaria by immunization with plasmid DNA encoding circumsporozoite protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1997.59

Circumventing genetic restriction of protection against malaria with multigene DNA immunization: CD8+ cell-, interferon gamma-, and nitric oxide-dependent immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1997.59

Plasmodium yoelii: 17-kDa hepatic and erythrocytic stage protein is the target of an inhibitory monoclonal antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1997.59

Identification and characterization of the protective hepatocyte erythrocyte protein 17 kDa gene of Plasmodium yoelii, homolog of Plasmodium falciparum exported protein 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1997.59

Introduction of foreign genes into tissues of living mice by DNA-coated microprojectiles

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1997.59

Genetic immunization is a simple method for eliciting an immune response

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1997.59

Intradermal gene immunization: the possible role of DNA uptake in the induction of cellular immunity to viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1997.59

Characterization of Plasmodium falciparum sporozoite surface protein 2

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1997.59

Human cytotoxic T lymphocytes against the Plasmodium falciparum circumsporozoite protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1997.59

Irradiated sporozoite vaccine induces HLA-B8-restricted cytotoxic T lymphocyte responses against two overlapping epitopes of the Plasmodium falciparum sporozoite surface protein 2

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1997.59

Location of human cytotoxic T cell epitopes within a polymorphic domain of the Plasmodium falciparum circumsporozoite protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1997.59

Molecular analysis of the association of HLA-B53 and resistance to severe malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1997.59

Identification of conserved antigenic components for a cytotoxic T lymphocyte-inducing vaccine against malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1997.59

Degenerate cytotoxic T cell epitopes from P. falciparum restricted by multiple HLA-A and HLA-B supertype alleles

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1997.59

An improved plasmid DNA expression vector for direct injection into skeletal muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1997.59

Potential DNA vaccine integration into host cell genome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1997.59

Clinical manifestations of Plasmodium falciparum malaria experimentally induced by mosquito challenge

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1997.59

Experimental challenge of volunteers with malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1997.59

A preliminary evaluation of a recombinant circumsporozoite protein vaccine against Plasmodium falciparum malaria. RTS,S Malaria Vaccine Evaluation Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1997.59

An OspA-Based DNA Vaccine Protects Mice against Infection with Borrelia burgdorferi

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1997.59

Specificity of Protective Immunity produced by X-irradiated Plasmodium berghei Sporozoites

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1997.59

Immunization of man against sporozite-induced falciparum malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1997.59

7 January 2021

Immunization of man against falciparum and vivax malaria by use of attenuated sporozoites

1 reference

https://api.crossref.org/works/10.1038%2FICB.1997.59

7 January 2021

Successful immunization of humans with irradiated malaria sporozoites: humoral and cellular responses of the protected individuals

1 reference

https://api.crossref.org/works/10.1038%2FICB.1997.59

7 January 2021

Nitric oxide-mediated antiplasmodial activity in human and murine hepatocytes induced by gamma interferon and the parasite itself: enhancement by exogenous tetrahydrobiopterin

1 reference

https://api.crossref.org/works/10.1038%2FICB.1997.59

7 January 2021

Attenuated vaccinia virus-circumsporozoite protein recombinants confer protection against rodent malaria.

1 reference

https://api.crossref.org/works/10.1038%2FICB.1997.59

7 January 2021

NYVAC-Pf7: a poxvirus-vectored, multiantigen, multistage vaccine candidate for Plasmodium falciparum malaria

1 reference

https://api.crossref.org/works/10.1038%2FICB.1997.59

7 January 2021

Do DNA vaccines induce autoimmune disease?

1 reference

https://api.crossref.org/works/10.1038%2FICB.1997.59

7 January 2021

Identifiers

DOI

10.1038/ICB.1997.59

1 reference

5 October 2017

1 reference